RIBON
Dead / Abandoned — Abandoned — no statement of use filed (as of 25 Nov 2019)
What this means for you
This application is over — abandoned 25 Nov 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86956777
- Mark type
- Stylized text
- Filed
- 29 Mar 2016
- Published for opposition
- 30 Aug 2016
- Abandoned
- 25 Nov 2019
- Attorney of record
- Michael J. Bevilacqua, Esquire
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the diagnosis and treatment of brain trauma, oncologic diseases, immunologic diseases, cardiovascular diseases, neurodegenerative diseases, inflammatory diseases, metabolic disorders, infectious diseases, respiratory diseases, inherited eye diseases; medical diagnostic biomarker assay to identify patients for treatment of brain trauma, oncologic diseases, immunologic diseases, cardiovascular diseases, neurodegenerative diseases, inflammatory diseases, metabolic disorders, infectious diseases, respiratory diseases, inherited eye diseases
Owner
- Ribon Therapeutics, Inc., Lexington, MA, US
- Ribon Therapeutics, Inc., Lexington, MA, US
Prosecution history
- 25 Nov 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 25 Nov 2019 — ABANDONMENT - NO USE STATEMENT FILED
- 01 May 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Apr 2019 — SOU EXTENSION 5 GRANTED
- 24 Apr 2019 — SOU EXTENSION 5 FILED
- 30 Apr 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Apr 2019 — SOU TEAS EXTENSION RECEIVED
- 18 Oct 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Oct 2018 — SOU EXTENSION 4 GRANTED
- 16 Oct 2018 — SOU EXTENSION 4 FILED
- 16 Oct 2018 — SOU TEAS EXTENSION RECEIVED
- 06 Apr 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Apr 2018 — SOU EXTENSION 3 GRANTED
- 04 Apr 2018 — SOU EXTENSION 3 FILED
- 04 Apr 2018 — SOU TEAS EXTENSION RECEIVED